These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fasciola hepatica tegumental coat impairs mast cells' ability to drive Th1 immune responses. Vukman KV; Adams PN; Metz M; Maurer M; O'Neill SM J Immunol; 2013 Mar; 190(6):2873-9. PubMed ID: 23418624 [TBL] [Abstract][Full Text] [Related]
3. Fasciola hepatica tegumental antigens induce anergic-like T cells via dendritic cells in a mannose receptor-dependent manner. Aldridge A; O'Neill SM Eur J Immunol; 2016 May; 46(5):1180-92. PubMed ID: 26931640 [TBL] [Abstract][Full Text] [Related]
4. The effects of Fasciola hepatica tegumental antigens on mast cell function. Vukman KV; Adams PN; Dowling D; Metz M; Maurer M; O'Neill SM Int J Parasitol; 2013 Jun; 43(7):531-9. PubMed ID: 23535069 [TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica tegumental coat antigen suppresses MAPK signalling in dendritic cells and up-regulates the expression of SOCS3. Vukman KV; Adams PN; O'Neill SM Parasite Immunol; 2013 Jul; 35(7-8):234-8. PubMed ID: 23495757 [TBL] [Abstract][Full Text] [Related]
6. Helminth antigens modulate human PBMCs, attenuating disease progression in a humanised mouse model of graft versus host disease. Healy M; Aldridge A; Glasgow AMA; Mahon BP; English K; O'Neill SM Exp Parasitol; 2022 Apr; 235():108231. PubMed ID: 35151653 [TBL] [Abstract][Full Text] [Related]
7. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Dowling DJ; Hamilton CM; Donnelly S; La Course J; Brophy PM; Dalton J; O'Neill SM Infect Immun; 2010 Feb; 78(2):793-801. PubMed ID: 19917714 [TBL] [Abstract][Full Text] [Related]
8. Glycans from Fasciola hepatica Modulate the Host Immune Response and TLR-Induced Maturation of Dendritic Cells. Rodríguez E; Noya V; Cervi L; Chiribao ML; Brossard N; Chiale C; Carmona C; Giacomini C; Freire T PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004234. PubMed ID: 26720149 [TBL] [Abstract][Full Text] [Related]
9. Fasciola hepatica Surface Coat Glycoproteins Contain Mannosylated and Phosphorylated N-glycans and Exhibit Immune Modulatory Properties Independent of the Mannose Receptor. Ravidà A; Aldridge AM; Driessen NN; Heus FA; Hokke CH; O'Neill SM PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004601. PubMed ID: 27104959 [TBL] [Abstract][Full Text] [Related]
10. Newly excysted juveniles (NEJs) of Fasciola gigantica induce mice liver fibrosis and M2 macrophage-like phenotype in vivo. Zhang Y; Mei X; Liang Y; Zhu B; Sheng Z; Shi W; Wang D; Huang W Microb Pathog; 2020 Feb; 139():103909. PubMed ID: 31805319 [TBL] [Abstract][Full Text] [Related]
11. Fasciola hepatica excretory-secretory products induce CD4+T cell anergy via selective up-regulation of PD-L2 expression on macrophages in a Dectin-1 dependent way. Guasconi L; Chiapello LS; Masih DT Immunobiology; 2015 Jul; 220(7):934-9. PubMed ID: 25758714 [TBL] [Abstract][Full Text] [Related]
12. Study of peritoneal macrophage immunophenotype in sheep experimentally infected with Fasciola hepatica. Ruiz-Campillo MT; Molina-Hernández V; Pérez J; Pacheco IL; Pérez R; Escamilla A; Martínez-Moreno FJ; Martínez-Moreno A; Zafra R Vet Parasitol; 2018 Jun; 257():34-39. PubMed ID: 29907190 [TBL] [Abstract][Full Text] [Related]
13. Fasciola hepatica products induce apoptosis of peritoneal macrophages. Guasconi L; Serradell MC; Masih DT Vet Immunol Immunopathol; 2012 Aug; 148(3-4):359-63. PubMed ID: 22819320 [TBL] [Abstract][Full Text] [Related]
15. Eosinophils Control Liver Damage by Modulating Immune Responses Against Frigerio S; da Costa V; Costa M; Festari MF; Landeira M; Rodríguez-Zraquia SA; Härtel S; Toledo J; Freire T Front Immunol; 2020; 11():579801. PubMed ID: 33042162 [TBL] [Abstract][Full Text] [Related]
16. Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica. Miller CM; Smith NC; Ikin RJ; Boulter NR; Dalton JP; Donnelly S PLoS One; 2009 May; 4(5):e5692. PubMed ID: 19478853 [TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory Effect of Fasciola hepatica Excretory-Secretory Products on Macrophages. Guasconi L; Serradell MC; Masih DT; Chiapello LS Methods Mol Biol; 2020; 2137():117-131. PubMed ID: 32399925 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Immune Regulatory Properties of Dendritic Cells During Fasciola hepatica Infection. Freire T Methods Mol Biol; 2020; 2137():181-190. PubMed ID: 32399929 [TBL] [Abstract][Full Text] [Related]
19. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Donnelly S; O'Neill SM; Sekiya M; Mulcahy G; Dalton JP Infect Immun; 2005 Jan; 73(1):166-73. PubMed ID: 15618151 [TBL] [Abstract][Full Text] [Related]
20. Fasciola hepatica Surface Tegument: Glycoproteins at the Interface of Parasite and Host. Ravidà A; Cwiklinski K; Aldridge AM; Clarke P; Thompson R; Gerlach JQ; Kilcoyne M; Hokke CH; Dalton JP; O'Neill SM Mol Cell Proteomics; 2016 Oct; 15(10):3139-3153. PubMed ID: 27466253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]